Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, February 8, 2013

Scientists announce new iPSCs-based treatment for myelin disorders

But first ask your doctor what damage your stroke caused to your myelin. Then you can ask what protocol there is to correct that.

Scientists announce new iPSCs-based treatment for myelin disorders


Researchers from the Rochester Medical Centre (URMC) released a new study today, where they exhibit for the first time, that neural stem cells derived from human induced pluripotent stem cells (hiPSCs) may hold the key for treating one day myelin-related conditions, like multiple sclerosis and various rare pediatric leukodystrophies.

In this animal study the researchers, led by Steven Goldman, were successful in creating myelin-producing cells. As aforementioned, the cells were created from an hiPSC line which in turn was derived from human skin cells. Goldman said that their study not only suggests that an hiPSC based treatment would be effective for myelin disorders but it also indicates that cells derived from iPSCs seemed to be more effective then the ones derived from embryonic stem cells.

According to the researchers, the study has great implications in the field of treating neurological conditions resulting from myelin loss. Myelin is an insulating material which forms a layer called the myelin sheath, which in turn plays an important role in the proper function of the central nervous system. Some indicative examples of such conditions are multiple sclerosis and a few extremely rare pediatric and commonly fatal conditions called pediatric leukodystrophies.

Myelin is produced by oligodendrocytes a type of cell derived from neural stem cells (NSCs). It has long been hypothesised that myelin-related conditions may be treatable with therapies that would introduce a "fresh" population of healthy neural stem cells that in turn would differentiate into oligodendrocytes regenerating the lost myelin.

No comments:

Post a Comment